Absolutely. This will be achieved with a 50% deat
Post# of 151626
Even achieving a good p-value (slightly greater than, say 0.005) the FDA (if given the data from Board) might conclude that the power is not good enough. However, under the circumstances, the information of "drug goodness" is very valuable to us investors, and, by reflection to the SP

One can wait calmly expecting the predictable outcome


